| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/2010 | US20100158958 Gastric reflux resistant dosage forms |
| 06/24/2010 | US20100158957 Aerosolized fluoroquinolones and uses thereof |
| 06/24/2010 | US20100158956 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
| 06/24/2010 | US20100158948 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a |
| 06/24/2010 | US20100158946 Secretory IgA and IgG Antibody Inducer |
| 06/24/2010 | US20100158931 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 06/24/2010 | US20100158924 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 06/24/2010 | US20100158921 Compositions and methods for inhibition of the jak pathway |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158916 Diagnostic biomolecule(s) |
| 06/24/2010 | US20100158914 Klotho beta |
| 06/24/2010 | US20100158907 Connective tissue growth factor fragments and methods and uses thereof |
| 06/24/2010 | US20100158905 Combination therapy of arthritis with tranilast |
| 06/24/2010 | US20100158897 Pai-1 modulators for the treatment of ocular disorders |
| 06/24/2010 | US20100158896 Antibody that specifically binds hyaluronan synthase |
| 06/24/2010 | US20100158895 Methods and compositions for reduction of side effects of therapeutic treatments |
| 06/24/2010 | US20100158894 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 06/24/2010 | US20100158885 Method and material for site activated complexing of biologic molecules |
| 06/24/2010 | US20100158884 Cascade |
| 06/24/2010 | US20100158883 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 06/24/2010 | US20100158869 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 06/24/2010 | US20100158867 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 06/24/2010 | US20100158864 Antiviral product |
| 06/24/2010 | US20100158863 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 06/24/2010 | US20100158862 Hepatitis C Virus Inhibitors |
| 06/24/2010 | US20100158861 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
| 06/24/2010 | US20100158860 Heterocyclic antiviral compounds |
| 06/24/2010 | US20100158858 Administration of carboline derivatives useful in the treatment of cancer and other diseases |
| 06/24/2010 | US20100158857 Compositions and methods for the inhibition of endothelial nitric oxide synthase activity |
| 06/24/2010 | US20100158855 Metap-2 inhibitor polymersomes for therapeutic administration |
| 06/24/2010 | US20100158854 Method for treatment of airway and apparatus and kit for use therewith |
| 06/24/2010 | US20100158850 Dendrimer based modular platforms |
| 06/24/2010 | US20100158849 Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant |
| 06/24/2010 | US20100158843 Novel 3-phenylpropanoic compound activators of receptors of ppar type and pharmaceutical/cosmetic compositions comprised thereof |
| 06/24/2010 | US20100158842 Natural skin whitener: 4-hydroxy-oxindole-3-acetic acid |
| 06/24/2010 | US20100158831 Viscosity Regulator, Method For The Production Thereof, And Use Thereof |
| 06/24/2010 | US20100158829 Method and Composition for Color Modulation |
| 06/24/2010 | US20100158824 Silicone polyether elastomer gels |
| 06/24/2010 | US20100158821 Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
| 06/24/2010 | US20100158819 Calcium Glycerophosphate for Treating and Preventing Respiratory Diseases or Conditions |
| 06/24/2010 | US20100158818 Antimicrobial n-chlorinated compositions |
| 06/24/2010 | US20100158799 Method and composition for bioactive agent release in vivo |
| 06/24/2010 | US20100158798 FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity |
| 06/24/2010 | US20100158797 Use of a2a adenosine receptor agonists |
| 06/24/2010 | US20100158796 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
| 06/24/2010 | DE102008064061A1 Feste Zusammensetzung mit dem Wirkstoff Rasagilin A solid composition containing the active ingredient rasagiline |
| 06/24/2010 | DE102008062878A1 Substituierte Furancarboxamide und ihre Verwendung Substituted Furancarboxamides and their use |
| 06/24/2010 | DE102008062863A1 Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung Substituted (thiophenyl-carbonyl) imidazolidinones and their use |
| 06/24/2010 | DE102008062825A1 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo [4,3-b]pyridazin-derivate 3- (3-pyrimidin-2-yl-benzyl) - [1,2,4] triazolo [4,3-b] pyridazine derivatives |
| 06/24/2010 | DE102008062689A1 Modifikation I der 4-({(4-Carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoesäure Modification I of the 4 - ({(4-carboxybutyl) [2- (2 - {[4- (2-phenylethyl) benzyl] oxy} phenyl) ethyl] amino} methyl) benzoic acid |
| 06/24/2010 | DE102008062688A1 Monohydrat der 4-({(4-Carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoesäure Benzoic acid monohydrate of 4 - - (methyl amino {(4-carboxybutyl) [{[4- (2-phenylethyl) benzyl] oxy} phenyl) ethyl 2- (2]}) |
| 06/24/2010 | DE102008061247A1 Inhibitoren der Dimethylarginin Dimethylaminohydrolase Inhibitors of dimethylarginine dimethylaminohydrolase |
| 06/24/2010 | DE102008037168A1 Verwendung von Sauerstoff zur Behandlung von Erkrankungen der Schleimhaut des Magen-Darm-Kanals Use of oxygen for the treatment of diseases of the mucosa of the gastrointestinal tract |
| 06/24/2010 | CA2747846A1 A formulation for the buccal transmucosal administration of setrons |
| 06/24/2010 | CA2747803A1 [2.2.2] bicyclic derivatives and methods of use |
| 06/24/2010 | CA2747715A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | CA2747677A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
| 06/24/2010 | CA2747565A1 Novel c-1analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation |
| 06/24/2010 | CA2747557A1 Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies |
| 06/24/2010 | CA2747427A1 Method for producing diamine derivative |
| 06/24/2010 | CA2747424A1 1-heterodiene derivative and harmful organism control agent |
| 06/24/2010 | CA2747365A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof |
| 06/24/2010 | CA2747359A1 Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof |
| 06/24/2010 | CA2747314A1 Treatment of vaginal atrophy in women with cardiovascular pathology risk |
| 06/24/2010 | CA2747311A1 Solid composition containing the ingredient rasagiline |
| 06/24/2010 | CA2747306A1 1,3,4-oxadiazole derivatives and their uses to treat diabetes |
| 06/24/2010 | CA2747287A1 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyrimidine derivatives |
| 06/24/2010 | CA2747252A1 Pyrazine derivatives useful as inhibitors of atr kinase |
| 06/24/2010 | CA2747219A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature |
| 06/24/2010 | CA2747022A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 06/24/2010 | CA2746990A1 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
| 06/24/2010 | CA2746764A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic |
| 06/24/2010 | CA2746585A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation |
| 06/24/2010 | CA2746549A1 Isoxazole derivatives for use as fungicides |
| 06/24/2010 | CA2746190A1 Controlled-release composition for producing sustained-release preparation containing udenafil |
| 06/24/2010 | CA2746077A1 Fused imidazole carboxamides as trpv3 modulators |
| 06/24/2010 | CA2745459A1 Thiazoles as cannabinoid receptor ligands |
| 06/24/2010 | CA2745299A1 Cyclohexanecarboxamide derivatives useful as inhibitors of cholesteryl ester transfer protein |
| 06/24/2010 | CA2745297A1 Pyrimidin-2-ylamino derivatives and their use to treat inflammation |
| 06/24/2010 | CA2745290A1 Thiadiazole-substituted arylamides |
| 06/24/2010 | CA2745279A1 Capecitabine rapidly disintegrating tablets |
| 06/24/2010 | CA2745059A1 A composition for use on skin and wounds |
| 06/24/2010 | CA2744935A1 New compounds |
| 06/24/2010 | CA2744888A1 Cysteine protease inhibitors |
| 06/24/2010 | CA2743965A1 A process for nanoemulsification of curcumin and derivatives of curcumin |
| 06/24/2010 | CA2743397A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis |
| 06/24/2010 | CA2742914A1 Substituted bicyclic imidazole derivatives as gamma secretase modulators |
| 06/24/2010 | CA2737335A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/24/2010 | CA2734677A1 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases |
| 06/24/2010 | CA2734403A1 Nicotine-containing product |
| 06/23/2010 | EP2199402A1 Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof |
| 06/23/2010 | EP2199401A1 Novel K04-0144 substances and process for production thereof |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
| 06/23/2010 | EP2199293A1 One-step process for preparing paliperidone and its oxalate salt |
| 06/23/2010 | EP2199292A1 7-azaindirubins, 7'-azaindirubins, 7-7'-diazaindirubin and the corresponding 3'-oxime ether derivates: production thereof, their production and use as a medicament |
| 06/23/2010 | EP2199291A1 Process for preparation of pimobendan hydrochloride |
| 06/23/2010 | EP2199289A1 Biologically active extract from Dendrobium plant, use thereof and process for preparing the same |
| 06/23/2010 | EP2199287A1 Substituted isoxazoline compound and pest control agent |
| 06/23/2010 | EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein |